☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
gastric cancers
Insights+ Key Biosimilars Events of May 2019
June 4, 2019
Biocon and Mylan's Ogivri (trastuzumab- biosimilar) Receives Health Canada's Approval for HER2-Positive Breast and Gastric Cancers
May 22, 2019
Load more...
Back to Home
